Navigation Links
FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
Date:3/12/2008

-Amended Agreement Accelerates Expected Timing of Final Analysis by One Year While Maintaining Comparable Powering of Interim and Final Results- -Dendreon to Hold Conference Call on Thursday, March 13, 2008 at 11:00 AM

ET-

SEATTLE, March 12 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that the U.S. Food and Drug Administration (FDA) has agreed to an amended Special Protocol Assessment (SPA) for the Phase 3 IMPACT (IMmunotherapy for Prostate AdenoCarcinoma Treatment, also known as D9902B) clinical trial of PROVENGE(R) (sipuleucel-T), the Company's investigational active cellular immunotherapy for the treatment of advanced prostate cancer. In addition, the FDA has reconfirmed that they would accept a positive interim or final analysis from the IMPACT trial to amend the Biologics License Application (BLA) for licensure of PROVENGE.

The amended SPA accelerates the expected timing of the final IMPACT results by approximately one year while maintaining comparable powering of the study's interim and final results. By increasing the number of events and decreasing the alpha (false positive error) spending function for the interim analysis, the Company is able to reduce the number of events for the final analysis (from 360 to 304) and still maintain a comparable statistical power for both the interim and final analyses. Interim results are still expected in the second half of 2008; however, final results are now expected in the second half of 2009 rather than 2010.

Based on the statistical plan in the amended SPA, if the treatment effect at the interim analysis for the IMPACT trial is consistent with the integrated results of the previous two completed pha
'/>"/>

SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. FDA Agrees to Review Cimzia(R) File for the Treatment of Rheumatoid Arthritis
2. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
3. Inverness Medical Innovations Agrees to Acquire Panbio Ltd.
4. Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
5. Mylan Announces Amendment to Bystolic(TM) (Nebivolol) Agreement
6. Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens Hospital
7. Barr Confirms Patent Challenge of Namenda(R) Tablets, 5mg & 10mg
8. ExonHit and bioMerieux Amend Their Strategic Partnership
9. Halozyme Therapeutics Amends Stockholder Rights Plan
10. Beanstalk Capital Ltd. and iCo Therapeutics Inc. amend arrangement agreement
11. Genmab Amends HuMax-CD4 Pivotal Study in CTCL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2008)...4, and Tuesday, November 25, ...St. Andrews by-the-Sea, New Brunswick, ... NOTE TO EDITORS: Photo, video and interview op...THE-SEA, NB, Nov. 19 /PRNewswire/ - The global for...bent on all stakeholders to look for environmental...
(Date:11/19/2008)...FirstCall/ -- Synvista Therapeutics, Inc. (AMEX: ...d that the FDA has received its application for 51...st kit. The 510(k) submission begins a 90-day rev...hether the kit can be distributed to labs througho... , "We are very pleased to announce the submis...
(Date:11/19/2008)... Bavarian Nordic,has inv...ayment of USD 25,million as allowed under the RFP... doses of the company,s IMVAMUNE(R) smallpox vacci...ecent submission of a clinical safety report,from...fected subjects, which,is part of the regulatory ...
(Date:11/19/2008)...ll/ - GeneNews Limited (TSX: GEN), a company focus...he early detection of diseases and personalized he...a Canadian Colorectal Cancer Advisory Board. Drs. ...y, Andy Smith and Mr. Barry Stein will advise Gene...or the Canadian commercialization of ColonSentry(T...
Breaking Biology Technology:Media Advisory - Atlantica BioEnergy Task Force Leaders' Roundtable 2Synvista Therapeutics Announces 510(k) Submission for Its HAPTOCHEK(TM) Test Kit 2Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission of Important IMVAMUNE(R) Data to The U.S. Health Authorities 2GeneNews appoints Canadian Colorectal Cancer Advisory Board 2GeneNews appoints Canadian Colorectal Cancer Advisory Board 3
..., , Adrian R. Elliott, Peer M. Schenk a...l Agriculture, Brisbane, Queensland , ,...scent Protein (GFP) from Aequorea victoria is a us... including plants and animals. The fluorescence ,... substrate or cofactors. Furthermore, , i...
..., , Helen Chun, Milhan Telatar and Rich...l of Medicine,Los Angeles, California , ...uncation Testing (PTT) is a method used to screen ...ranslation termination mutations. The gene respons...e ataxia-telangiectasia, ATM (ataxia-telangiectasi...
..., , Derek Cody and Laura G. Leff, Depar...ity, Kent, Ohio , , Introductio...ty in natural environments is problematic , ...teria and the large number , of species t...iological , traits of most microbes are a...
..., , Russell J. Buono and Paul J. Linser...da, 9505 Ocean Shore Blvd.,St. Augustine, Flori... The production of transgenic animals has prove... developmentally regulated genes. The traditional ... into fertilized embryos is tedious and , ...
Other Biology Technology:Quantitative Analysis of GFP in Plant Extracts Using the VersaFluor Fluorometer System 2Quantitative Analysis of GFP in Plant Extracts Using the VersaFluor Fluorometer System 3Protein Truncation Tests Using the DCode System 2Protein Truncation Tests Using the DCode System 3Analysis of Bacterial Assemblage Genetic Diversity in Environmental Samples Using the DCode System 2Analysis of Bacterial Assemblage Genetic Diversity in Environmental Samples Using the DCode System 3Analysis of Bacterial Assemblage Genetic Diversity in Environmental Samples Using the DCode System 4Analysis of Bacterial Assemblage Genetic Diversity in Environmental Samples Using the DCode System 5Transgenic Zebrafish by Electroporation 2Transgenic Zebrafish by Electroporation 3Transgenic Zebrafish by Electroporation 4Transgenic Zebrafish by Electroporation 5
(Date:11/19/2008)...s, jellyfish - have the simplest eyes that exist. ...eptor cell and a pigment cell. These minimal eyes,...ted by Charles Darwin as the first eyes to appear ...llow the animal to sense the direction of light. T...g towards light exhibited by many zooplankton larv...
(Date:11/19/2008)...forming clouds to the flow of the molten Earth,s c...ngine to the coursing blood in your veins, from th...icroscopic animals in the ocean, many of nature,s .... , The 61st Annual Meeting of the American Phys...akes place from November 23-25 at the San Antonio ...
(Date:11/19/2008)... scientists on the hunt for a better way to clean ...d that lets them watch molecules break down on the...s are formed and broken. , "We can see the vibra...les," said researcher Michael Wong. "By watching t...sity with time, we can watch how molecules transfo...
(Date:11/19/2008)...biggest threats to today,s farmlands is the loss o...r (SOM) from poor land-management practices. The p... everything from providing plants with proper nutr...he prevention of soil erosion. Sustainable managem...aintaining soil productivity, but being able to me...
Breaking Biology News(10 mins):Uncovering secrets of life in the ocean 2The physics of star-forming clouds and the urban environment 2The physics of star-forming clouds and the urban environment 3The physics of star-forming clouds and the urban environment 4The physics of star-forming clouds and the urban environment 5The physics of star-forming clouds and the urban environment 6Researchers shed new light on catalyzed reactions 2Researchers shed new light on catalyzed reactions 3A model to measure soil health in the era of bioenergy 2Exosome Diagnostics Announces Additions to Management Team 7446 1Exosome Diagnostics Announces Additions to Management Team 7446 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New Innovative Low Dose Contraceptive Patch 2950 1Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New Innovative Low Dose Contraceptive Patch 2950 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New Innovative Low Dose Contraceptive Patch 2950 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New Innovative Low Dose Contraceptive Patch 2950 4Peregrine Pharmaceuticals to Report First Quarter FY 2009 Financial Results 7443 1Peregrine Pharmaceuticals to Report First Quarter FY 2009 Financial Results 7443 2Filter Markets Discover the Growth Segments 7441 1Filter Markets Discover the Growth Segments 7441 2Filter Markets Discover the Growth Segments 7441 3
...en the bacterium Listeria monocytogenes invades th...keleton to invade other cells. In a report publish... of scientists provide insight into the molecular ...research appears as the "Paper of the Week" in the...stry, an American Society for Biochemistry and Mol...
...at is the connection between a fly’s aerodynamic s...most brilliant X-rays, located at the Advanced Pho...nne National Laboratory, a cardiac molecular motor...colleagues from the Illinois Institute of Technolo...that and other questions. , The research team, inc...
...uth America,s giant Pantanal wetlands, one of the ... risk from intensive peripheral agricultural, indu... be compounded by climate change, United Nations U...00 square kilometers ?an area roughly equal to Flo...is the world,s largest freshwater wetland, of acti...
...e genes TEL2 and MYC cooperate with each other to ...r B-cell lymphoma. This finding, from investigator...lished in the current issue of Molecular Cell Biol...the antibody-producing cells (B lymphocytes) multi.... The St. Jude researchers report that TEL2 cooper...
Other Biology News:Scientists discover that host cell lipids facilitate bacterial movement 2X-Ray Beams And Fruit Fly 'Flight Simulator' Aid Scientists' View Of Muscle Power 2X-Ray Beams And Fruit Fly 'Flight Simulator' Aid Scientists' View Of Muscle Power 3South America's vast pantanal wetland may become next everglades, UNU experts warn 2South America's vast pantanal wetland may become next everglades, UNU experts warn 3South America's vast pantanal wetland may become next everglades, UNU experts warn 4South America's vast pantanal wetland may become next everglades, UNU experts warn 5South America's vast pantanal wetland may become next everglades, UNU experts warn 6TEL2 gene cooperates with MYC gene to provoke B-cell lymphomas 2TEL2 gene cooperates with MYC gene to provoke B-cell lymphomas 3
SYBR Green II RNA gel stain is a sensitive nucleic acid gel stain that has bright fluorescence when bound to RNA and low background in gels, making it ideal for use with either formaldehyde/agarose
Sirtuin 7 (SIRT7) Rabbit anti-Human Polyclonal Antibody Immunogen: Synthetic peptide - KLH conjugated Family: Other Recommended Storage: Long term: -20C; Short term: +4C
...ophions newly introduced QPatch HT is taking autom...l level. With its ability to generate thousands of...ling new screening paradigms in ion channel drug d...ing with the same high quality afforded by convent...
...icroarrays designed for RNA aptamer screening and ... powerful Paraflo microfluidic on-chip synthesis p...f our comprehensive DNA/RNA Aptamer Microarray Ser...r Microarray contains greater than 1500 known apta...
Biology Products: